血府逐瘀汤联合体外反搏治疗对心血瘀阻证心绞痛患者发作情况及肱动脉内皮依赖性血管舒张功能的影响

Effect of Xuefu Zhuyu Decoction combined with external counterpulsation therapy on attacks and brachial artery brachial artery flow-mediated dilation in patients with angina pectoris of heart blood stasis syndrome

  • 摘要:
    目的  探讨血府逐瘀汤联合体外反搏对心血瘀阻证心绞痛患者疾病发作情况及肱动脉内皮依赖性血管舒张功能(FMD)的影响。
    方法  选取2022年3月—2023年12月来院就诊的稳定型冠心病(SCAD)心绞痛患者80例为研究对象,并将其随机分为对照组(40例)和治疗组(40例)。对照组采用常规治疗和血府逐瘀汤治疗,治疗组在对照组的基础上增加体外反搏装置治疗。记录2组患者治疗前后心绞痛发作情况; 采用彩色多普勒超声诊断仪测定肱动脉FMD; 采用心电图仪测定连续5 min正常R-R间期平均值的标准差(SDANN)、正常窦性心搏R-R间期的标准差(SDNN)、相邻R-R间期差值的均方根(rMSSD)等心率变异性指标; 采用全自动生化分析仪测定高密度脂蛋白胆固醇(HDL-C)、低密度脂蛋白胆固醇(LDL-C)、总胆固醇(TC)及甘油三酯(TG)等血脂指标; 采用硝酸还原酶法检测血清一氧化氮(NO)水平; 采用酶联免疫吸附测定(ELISA)检测血清血管内皮素-1(ET-1)水平。记录2组不良事件发生情况。
    结果  治疗后, 2组发作频率较治疗前下降,持续时间较治疗前缩短,且治疗组心绞痛发作频率低于对照组,心绞痛持续时间短于对照组,差异有统计学意义(P < 0.05)。治疗后, 2组FMD、NO水平较治疗前上升, ET-1水平较治疗前下降,且治疗组FMD、NO水平高于对照组, ET-1水平低于对照组,差异有统计学意义(P < 0.05)。治疗后, 2组SDANN、SDNN、rMSSD较治疗前升高,且治疗组SDANN、SDNN、rMSSD高于对照组,差异有统计学意义(P < 0.05)。治疗后, 2组HDL-C水平较治疗前上升, LDL-C、TC、TG水平较治疗前下降,且治疗组HDL-C水平高于对照组, LDL-C、TC、TG水平低于对照组,差异有统计学意义(P < 0.05)。2组患者治疗期间未发生严重不良反应,无异常生命体征,肝肾功能正常。
    结论  血府逐瘀汤联合体外反搏能够有效缓解心血瘀阻证心绞痛患者的临床症状,降低心绞痛发作频率,缩短心绞痛持续时间,改善肱动脉FMD、内皮功能、心率变异性和血脂水平,且安全性良好。

     

    Abstract:
    Objective  To investigate the effect of Xuefu Zhuyu Decoction combined with external counterpulsation therapy on angina pectoris attacks and brachial artery flow-mediated dilation (FMD) in patients with angina pectoris of heart blood stasis syndrome.
    Methods  A total of 80 patients with stable coronary artery disease (SCAD) and angina pectoris who visited our hospital between March 2022 and December 2023 were selected as study subjects and randomly divided into control group (40 cases) and treatment group (40 cases). The control group received conventional treatment and Xuefu Zhuyu Decoction, while the treatment group received external counterpulsation therapy in addition to the control group′s treatment. The angina pectoris attacks before and after treatment in both groups was recorded. Color Doppler ultrasound was used to measure brachial artery FMD; electrocardiogram was used to measure heart rate variability indicators, including the standard deviation of the average of normal to normal intervals (SDANN) for 5 consecutive minutes, standard deviation of normal to normal intervals (SDNN), and square root of the mean of the sum of the squares of the differences between consecutive N-N intervals (rMSSD). A fully automatic biochemical analyzer was used to measure blood lipid indicators such as high-density lipoprotein cholesterol (HDL-C), low-density lipoprotein cholesterol (LDL-C), total cholesterol (TC), and triglycerides (TG). Nitrate reductase method was used to detect serum nitric oxide (NO) levels, and enzyme-linked immunosorbent assay (ELISA) was used to detect serum endothelin-1 (ET-1) levels. Adverse events in both groups were recorded.
    Results  After treatment, the attack frequency of angina pectoris decreased and duration shortened in both groups compared with before treatment, and the attack frequency of angina pectoris was lower and duration shorter in the treatment group than in the control group (P < 0.05). After treatment, FMD and NO levels increased, and ET-1 levels decreased in both groups compared with before treatment, and FMD and NO levels were higher, while ET-1 levels were lower in the treatment group than in the control group (P < 0.05). After treatment, SDANN, SDNN, and rMSSD increased in both groups compared with before treatment, and SDANN, SDNN, and rMSSD were higher in the treatment group than in the control group (P < 0.05). After treatment, HDL-C levels increased, while LDL-C, TC, and TG levels decreased in both groups compared with before treatment, and HDL-C levels were higher, while LDL-C, TC, and TG levels were lower in the treatment group than those in the control group (P < 0.05). No serious adverse reactions occurred during treatment in both groups, and vital signs were normal, with normal liver and kidney function.
    Conclusion  Xuefu Zhuyu Decoction combined with external counterpulsation can effectively alleviate clinical symptoms, reduce the frequency of angina pectoris attacks, shorten the duration of angina pectoris, improve brachial artery FMD, endothelial function, heart rate variability, and blood lipid levels in patients with angina pectoris of heart blood stasis syndrome. Besides, it has higher safety.

     

/

返回文章
返回